Healthcare

Low-cost Ozempic copies launch in India as Novo Nordisk’s patent expires

One firm plans to make a semaglutide jab at a starting price of 1,290 rupees a month

AC Health's CEO Paolo Borromeo says the company is working on integrating all its healthcare assets.
THE LEADERSHIP PLAYBOOK

Big believer in ‘profit and purpose’: CEO of Ayala’s healthcare arm builds ‘ecosystem’ in Philippines

Ayala Corporation’s healthcare business unit is back in the black again and looking to expand

Sunway Medical Centre is a private hospital under Sunway Healthcare. The healthcare arm of Sunway Group priced its IPO at RM1.45 per share.

Sunway Healthcare jumps 27.6% on Bursa debut in Malaysia’s biggest IPO in nine years

It has raised RM3.3 billion from its base offering and overallotment option

Singapore is among the fastest-aging societies globally, with about 21% of the resident population aged 65 and above in 2026.

TPG establishes elderly healthcare firm in Singapore, Malaysia

Demand for nursing homes and community-based care is rising

Q&M says the deal supports its “long-term strategic objectives of expanding its footprint beyond Singapore and strengthening its presence in the Asia-Pacific region”.

Q&M to buy Australian dental group for A$144.5 million

The acquisition target has a network of more than 40 clinics and about 120 dentists

New riders to be sold will differ in their coverage, with some covering only up to public hospital stays and some including private hospital stays as well.

New IP rider premiums to cost at least 30% less, with one insurer offering an 84% reduction

All seven insurers will be launching new Integrated Shield Plan rider products by Apr 1

The pricing values Sunway Healthcare at RM16.7 billion, with the company’s shares scheduled to commence trading on Mar 18.

Sunway Healthcare sets final price for RM2.86 billion IPO, Malaysia’s largest in nine years 

The IPO includes 1.97 billion shares priced at RM1.45 apiece for institutional and retail investors

Established in 2002 and listed in Shenzhen in 2009, Aier ran nearly 900 eye hospitals, eye centres and clinics as of the end of 2023.

China’s biggest eye hospital chain Aier plans Hong Kong listing: sources

Aier trades in Shenzhen and has a market capitalisation of about 96 billion yuan

TPG may also decide to keep its stake in the Asia OneHealthcare.

TPG considers sale or IPO of Malaysia-based Asia OneHealthcare: sources

A deal might value the medical services provider at as much as RM30 billion

Dr Loo Choon Yong, executive chairman of Raffles Medical Group, takes a long-term view of the business.
HOCK LOCK SIEW

As Raffles Medical celebrates its golden jubilee, the doctor calls for more patience

Growth from the group’s defensive plays in China and Vietnam will take time